What's behind the rise of U.S. manufacturers “nearshoring” to Mexico? In this report, fellow David A. Gantz explores the historical drivers fueling this trend and the reasons why Mexico may struggle to attract foreign investment in the near future.
Under President Andrés Manuel López Obrador, Mexico is squandering a once-in-a-generation opportunity to encourage significant new foreign investment. His successor will need to reverse course, writes David A. Gantz, the Will Clayton Fellow in Trade and International Economics.
This policy report examines the push and pull factors that contribute to the formation of so-called “migrant caravans” and offers policy recommendations to staunch the flow of migrants through Mexico.
This report finds that America's largest companies could be increasing their profits by identifying opportunities to reign in the costs of health insurance coverage — while still maintaining or improving the quality of benefits for their employees.
This report explores the current situation in Palestinian-Israeli dynamics and concludes that the only real solution is a return to the two-state paradigm. Peace and security — for both Israelis and Palestinians — will come through mutual recognition of statehood and clearly defined and respected international borders, the author writes.
A regulation from the Centers for Medicare and Medicaid Services (CMS) required that, starting January 1, 2021, all U.S. hospitals publicly display the cash price as well as the minimum and maximum negotiated charge for 300 “shoppable services.”
Vivian Ho, Alan Beltran Lara, David Ruiz, Peter Cram, M.D., Marah ShortMay 12, 2022
This report finds that less than half of Texas hospitals are complying with federal price transparency regulations, despite a measure passed by the state Legislature intended to increase the financial penalty for noncompliance.
Vivian Ho, Marah Short, Vivian Ye, Patrick SolcherMarch 21, 2022
In this report, the authors outline the U.S. federal budget process for scientific R&D, discuss trends in federal R&D funding and provide an outlook for federal scientific R&D funding during the Biden administration.